Fatty Liver

We are actively researching a study medication that may possibly accelerate fat metabolism and treat the underlying cause of type 2 diabetes and nonalcoholic steatohepatitis (NASH).

You may be more likely to develop NASH if you have a history of type 2 diabetes, obesity, high blood pressure and high levels of fats such as triglycerides or abnormal cholesterol levels.

When a fatty liver moves on to a more severe level of liver injury, it is called nonalcoholic steatohepatitis (NASH).

The study medication, uses a natural metabolic process for fat selective weight loss.

You May Qualify If You Are:

At least 18 years of age

An overweight and/or obese adult

An adult living with type 2 diabetes

At least 1 unsuccessful dietary effort to lose weight

You may receive financial compensation for participating if you complete all the steps in this study.

First Name

Last Name

Phone Number

Email Address

*How did you hear About Us?

By submitting this form, you agree to receive email and text message notifications about this and other studies you enroll in. You can unsubscribe at any time

All information provided is confidential and will not be given or sold to any other agency without prior consent.